Peter Wolff, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 875 Wesley St Ste 230, Arlington, WA 98223 Phone: 360-435-6097 Fax: 360-435-1871 |
News Archive
Bristol-Myers Squibb Company and Isis Pharmaceuticals have announced a collaboration to discover, develop and commercialize novel antisense drugs targeting proprotein convertase subtilisin kexin 9 (PCSK9) for the prevention and treatment of cardiovascular disease.
USA Today: "In a backlash against President Obama's health care legislation that stretches from Virginia to California, lawmakers in more than two-thirds of the states are scrambling to undercut the bill before it even passes Congress." Legal scholars say that state legislation isn't the final word, however. "The state measures are likely to be challenged in court, setting up new legal battles over whether federal law can trump state laws.
Dr. Michael G. Malkowski, Hauptman-Woodward senior research scientist, has received a $6.7 million grant from the National Institutes of Health in support of his work to establish the Membrane Protein Structural Biology Consortium (mpsbc.org) as one of nine centers in the United States responsible for determining membrane protein structures within a larger NIH biology-based initiative.
Former President Bill Clinton and U.N. Secretary-General Ban Ki-moon in New York on Thursday launched MASSIVEGOOD - an initiative that allows travelers to make a $2 donation "to fight deadly diseases whenever they buy a plane ticket, book a hotel room or rent a car," Bloomberg/BusinessWeek reports (Varner, 3/4).
During an appeal to government and private donors to pledge money to the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday, UNAIDS Executive Director Michel Sidibe warned of the repercussions tightening budgets could play in the global fight against HIV/AIDS, the Associated Press reports.
› Verified 6 days ago